Skip to main content
. 2020 Jun 9;3(4):583–597. doi: 10.1021/acsptsci.0c00023

Table 2. Pathological Disorders Characterized by Altered TFF Expression and Potential Therapeutic Effect.

Location Pathologic disorder Therapeutic effect Refs
Gastrointestinal tract Inflammatory bowel diseases, intestinal and gastric damage, oral mucositis, diabetes Gastrointestinal epithelium repair and protection, β-cells proliferation (77,78,99,140,141,149158)
       
Ocular system Dry eye disease, corneal wounds Ocular surface damage repair (146,159)
       
Urinary tract Chronic kidney disease, nephrolithiasis Kidney damage repair and calcium oxalate crystal growth inhibitor (1,160163)
       
Respiratory tract Asthma, nasal allergic mucosa, mustard lung, chronic obstructive pulmonary disease, chronic rhinosinusitis, bronchopathy Airway remodelling limitation, mucus viscosity modulation, immune regulation, lung protection and repair. (164174)
       
Nervous system Depression Antidepressant (175,176)